Joseph H. Antin, MD
Professor, Department of Medicine, Harvard Medical School
Senior Physician, Oncology, Brigham And Women's Hospital
Chief, Adult Oncology Hematopoietic Stem Cell Transplantation Program, Dana-Farber Cancer Institute
DF/HCC Program AffiliationLeukemiaLymphoma and Myeloma
My principle research interests are in the prevention and therapy of graft-versus-host disease (GVHD) and in the use of graft-versus-leukemia to eradicate blood disorders. We have a series of clinical trials available to evaluate several different strategies to prevent GVHD, such as T cell depletion and the use of novel immunosuppressive agents. In addition, we are committed to graft engineering and vaccine development to enhance the ability of transplantation to control blood diseases.
View All Publications